Pharmacy Connect Podcast: PCSK9 Inhibitors
Title: PCSK9 Inhibitors: Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management
Special guest: Joseph Saseen, PharmD
Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Objectives
- Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines
- Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia.
- Describe the role of the pharmacist in patient education and counseling on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing.
CE LINK HERE:
https://www.pharmacytimes.org/on-demand/pcsk9-inhibitors-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-with-hyperlipidemia-management
PTCE - Pharmacy Times Continuing Education